Liminal Biosciences (LMNL) Competitor Comparison
We are evaluating the key criteria listed to compare Liminal Biosciences (LMNL) against its competitors in the Biotechnology industry.
Market Capitalization
316 / 368Gross Profits
161 / 278Total Revenue
257 / 300EBITDA
95 / 337Free Cashflow
133 / 352Quick Ratio
283 / 357Earnings per Share
327 / 359Dividend yield
0 / 6Total Cash
312 / 358Performance 3 years
310 / 368Performance 5 years
367 / 368Performance 10 years
357 / 368Linearity 3 years
306 / 368Linearity 5 years
312 / 368Linearity 10 years
157 / 368Total Rank
330 / 368Dividend Rank
188 / 368Valuation Rank
355 / 368Piotroski Rank
294 / 368Muliplier Rank
141 / 368Total Cash - LMNL ranking 312 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.